Clinical Trial

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Name: Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy — clinical trial record (NCT05518578)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2022-08-24; most recent amendment 2026-04-16.

Status change: Not Yet Recruiting → Recruiting 2023-03-16

Trial Details

NCT Number	NCT05518578
Lead Sponsor	Supernus Pharmaceuticals, Inc.
Conditions	Epilepsy, Seizures, Epileptic
Enrollment	60 participants
Start Date	2023-02-07
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-21